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The structural genes for Shiga toxin, designated stx A and stx B, were cloned from Shigella dysenteriae type
1 3818T, and a nucleotide sequence analysis was performed. Both stx A and stx B were present on a single
transcriptional unit, with stx A preceding stx B. The molecular weight calculated for the processed A subunit
was 32,225, while the molecular weight of the processed B subunit was 7,691. Comparison of the nucleotide
sequences for Shiga toxin and Shiga-like toxin I (SLT-I) from Escherichia coli revealed that the genes for Shiga
toxin and SLT-I were greater than 99% homologous; three nucleotide changes were detected in three separate
codons of the A subunits. Only one of these codon differences resulted in a change in the amino acid sequence:
a threonine in Shiga toxin at position 45 of the A subunit compared with a serine in the corresponding position
in SLT-I. Furthermore, Shiga toxin and SLT-I had identical signal peptides for the A and B subunits, as well
as identical ribosome-binding sites, a putative promoter, and iron-regulated operator sequences. These findings
indicate that Shiga and SLT-I are essentially the same toxin. Southern hybridization studies with total cellular
DNA from several Shigella strains and internal toxin probes for SLT-I and its antigenic variant SLT-II showed
that a single fragment in S. dysenteriae type 1 hybridized strongly with the internal SLT-I probe. Fragments
with weaker homology to the SLT-I probe were detected in S. flexneri type 2a but no other shigellae. No
homology between the Shiga-like toxin II (SLT-II) probe and any of the Shigella DNAs was detected. Whereas
SLT-I and SLT-II are phage encoded, no phage could be induced from S. dysenteriae type 1 or other Shigella
spp. tested. These results suggest that the Shiga (SLT-I) toxin genes responsible for high toxin production are
present in a single copy in S. dysenteriae type 1 but not in other shigellae. The findings further suggest that
SLT-II genes are absent in shigellae, as are toxin-converting phages.
Shiga toxin is a cell-associated protein toxin composed of
one copy of an A subunit (molecular weight estimated as
32,000) and five copies of a B subunit (molecular weight
estimated as 7,700) (8, 38). The toxin inhibits protein syn-
thesis in eucaryotic cells by cleaving the N-glycosidic bond
at adenine 4324 in 28S rRNA (Y. Endo, K. Tsurugi, T.
Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi, Eur. J.
Biochem., in press). The mode of action of Shiga toxin is
therefore identical to that of the plant toxin ricin (10). The
biological and biochemical properties of Shiga toxin have
recently been reviewed by O'Brien and Holmes (27).
Shigella species other than Shigella dysenteriae type 1 and
certain strains of Escherichia coli, Salmonella typhimurium,
Vibrio cholerae, and Campylobacter jejuni produce low
levels of a cytotoxin(s) that is neutralizable by antibodies
against purified Shiga toxin from S. dysenteriae type 1 (30,
32; A. D. O'Brien, M. E. Chen, R. K. Holmes, J. Kaper, and
M. Levine, Letter, Lancet, i:77-78, 1984; M. A. Moore,
M. J. Blazer, G. I. Perez-Perez, and A. D. O'Brien, submit-
ted for publication). Some strains of E. coli produce toxin in
amounts equivalent to those produced by strains of S.
dysenteriae type 1 (23, 30). E. coli that produce such
elevated levels of toxin have been associated with outbreaks
and sporadic cases of diarrhea (5, 37), hemorrhagic colitis
(23, 34), and hemolytic uremic syndrome (19, 23).
Toxins produced by organisms other than S. dysenteriae
type 1 that are neutralizable with antibodies against purified
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Shiga toxin are referred to as Shiga-like toxins (SLTs). The
SLT produced at high levels by E. coli, SLT-I, is also
referred to as Vero toxin or Vero toxin type 1 due to its
cytotoxic activity on Vero cells. The immunological, biolog-
ical, and biochemical properties of purified Shiga toxin and
purified SLT-I from E. coli are virtually identical (28, 42;
A. D. O'Brien, T. A. Lively, T. W. Chang, and S. L.
Gorbach, Letter, Lancet ii:573, 1983).
The E. coli SLT-I structural genes (slt-I A and slt-I B) are
carried on temperate bacteriophages (31, 41). The amino
acid compositions of the SLT-I A and B subunits predicted
from the DNA sequences (3, 7, 18) are nearly identical to the
amino acid compositions of the A and B subunits of Shiga
toxin experimentally determined by Donohue-Rolfe et al.
(8). In addition, the predicted amino acid sequence of the B
subunit of SLT-I (3, 7, 18) is identical to the amino acid
sequence of the B subunit of Shiga toxin experimentally
determined by Seidah et al. (38), and the amino acid se-
quence of the A subunit shares limited homology with the A
subunit of ricin (3, 7).
An antigenic variant of SLT-I, referred to as SLT-II or
Vero toxin type 2, has recently been described in entero-
hemorrhagic strains of E. coli (43; S. M. Scotland, H. R.
Smith, and B. Rowe, Letter, Lancet ii:885-886, 1985). The
structural genes of SLT-II, slt-II A and slt-II B, share
approximately 55% overall nucleotide and amino acid se-
quence homologies with the structural genes of SLT-I (17).
Recent data on the mode of action of SLT-II indicate that,
like ricin and Shiga toxin, it is a 28S rRNA glycosidase
(Endo et al., in press).
The genes for high-level production of Shiga toxin, desig-
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nated stx, have recently been cloned in vivo and mapped to
a location near pyrF on the chromosome of S. dysenteriae
type 1 (39). Here we report the in vitro cloning of the
structural genes for Shiga toxin, stx A and stx B, from total
cellular DNA of S. dysenteriae type 1 3818T. The nucleotide
sequences of the Shiga toxin genes were compared with the
previously reported sequences of SLT-I. In addition, South-
ern hybridization studies were conducted to assess the
prevalence of SLT and toxin-converting phage sequences in
various Shigella species.
MATERIALS AND METHODS
Bacterial strains and plasmids. S. dysenteriae type 1 3818T
(Centers for Disease Control enteric reference number 3818-
69), S. dysenteriae type 1 60R, S. flexneri type 2a M4243, S.
boydii type 1, and S. sonnei were obtained from S. B.
Formal of the Walter Reed Army Institute of Research
(Washington, D.C.). In this report the last two strains are
designated S. boydii SF-bl and S. sonnei SF-sl. S. dysen-
teriae type 1 3818T is toxigenic and invasive. It was isolated
in 1969 from the stool of a patient with dysentery during an
epidemic of shigellosis in Central America (24). The E. coli
minicell-producing strain P678-54 described by Adler et al.
(1) was obtained from C. L. Pickett of the Uniformed
Services University (Bethesda, Md.).
Cosmid pHC79 (15) was used for the initial cloning; and
plasmids pBR322, pBR328, pACYC184, pUC18, and pUC19
were used for subcloning as described by Maniatis et al. (22).
Recombinant plasmid pJN25 was described by Newland et
al. (26) and carries the intact structural genes for SLT-I.
Recombinant plasmids pJN31, containing a 250-base-pair
(bp) HindIII to HpaI internal fragment from the slt-I A gene,
and pNN76, containing a 5-kilobase-pair (kbp) EcoRI frag-
ment, including the slt-II A and B genes, were obtained from
J. W. Newland of the Walter Reed Army Institute of
Research.
Media, enzymes and biochemicals. Bacteria were routinely
cultured in LB medium (22). Strains tested for toxin produc-
tion were grown in Chelex-treated glucose syncase medium
(30) or Trypticase soy broth (BBL Microbiology Systems,
Cockeysville, Md.). Media were supplemented as indicated
in the text with the following antibiotics (Sigma Chemical
Co., St. Louis, Mo.) at the indicated concentrations: ampi-
cillin, 100 ,ug/ml; tetracycline, 15 p.g/ml; and chlorampheni-
col, 30 ,g/ml.
Restriction enzymes were purchased from Bethesda Re-
search Laboratories (Gaithersburg, Md.); Boehringer Mann-
heim Biochemicals (Indianapolis, Ind.); or New England
BioLabs, Inc. (Beverly, Mass.). DNA polymerase I (Klenow
enzyme), calf intestinal alkaline phosphatase, and T4 DNA
ligase were purchased from Boehringer Mannheim. The
enzymes were used according to the recommendations of the
supplier. Lambda in vitro packaging kits and nick-translation
kits were purchased from Bethesda Research Laboratories
and were used according to the instructions of the supplier.[a-35S]dATP (500 Ci/mmol) and [35S]methionine (800 Ci/
mmol) were purchased from New England Nuclear Research
Products (Boston, Mass.). [a-32P]dCTP (3,000 Ci/mmol) was
purchased from Amersham Corp. (Arlington Heights, Ill.).
Preparation of plasmid, cellular, and phage DNA. Plasmid
and cellular DNAs were prepared by the method described
by Maniatis et al. (22). Phage from E. coli C600(933J) or E.
coli C600(933W) was obtained after induction with mitomy-
cin C by previously described methods (12). Phage DNA was
extracted with formamide by previously published proce-
dures (6). Lambda DNA was purchased from Bethesda
Research Laboratories.
Phage induction. Experiments to induce phage from S.
dysenteriae type 1 3818T and 60R, S. flexneri M4243, S.
sonnei SF-sl, and S. boydii SF-bl with UV light or mitomy-
cin C were performed as described previously (12, 31). E.
coli HB101 and E. coli C600 were used as hosts to plaque
phage.
Cloning and subcloning. Cloning of the Shiga toxin genes
from S. dysenteriae type 1 3818T and all manipulations of
toxin-positive clones were conducted under BL3-EK1 con-
tainment (11). Cosmid cloning was performed essentially as
described by Maniatis et al. (22). Transductants were
screened for toxin production with a colony blot assay which
immunochemically detects the B subunit of Shiga toxin (42).
Colony blot-positive transductants were tested for biologi-
cally active toxin by the HeLa cell cytotoxicity assay (14).
Neutralization of cytotoxicity was performed with rabbit
antiserum against purified Shiga toxin (29), rabbit antiserum
against crude SLT-II (43), a mixture of anti-Shiga and
anti-SLT-II, and monoclonal antibody (MAb) 13C4 pro-
duced against SLT-I (42). Normal rabbit serum and MAbs
against cholera toxin (16) were used as control antibodies.
Cytotoxicity and neutralization assays. Bacteria were as-
sayed for toxin as described previously (30), and neutraliza-
tion assays were performed by previously published meth-
ods (23).
Minicell analysis and immunoprecipitation. Minicell exper-
iments were performed by the method described by Meagher
et al. (25). The labeled proteins were extracted with poly-
myxin B (100 ,ug/ml) for 45 min at 37°C and then analyzed on
sodium dodecyl sulfate-15% polyacrylamide gels (21). Im-
munoprecipitation of the extracted proteins was performed
essentially as described by Kessler (20). Rabbit antisera (100
,lI of a 1:100 dilution of anti-Shiga or normal rabbit serum) or
MAbs (100 ,ul of ammonium sulfate-concentrated culture
supernatants) of anti-SLT-I (MAb 13C4 or MAb 16E6) or
anti-cholera toxin (MAb 32D3) were mixed overnight at 4°C
with the labeled proteins (106 cpm per sample). The follow-
ing day a second antibody (1 ,ul of goat anti-mouse immuno-
globulin G [IgG] and IgM heavy and light chains; Boehringer
Mannheim) was added to facilitate precipitation. The sam-
ples were incubated for an additional hour at 37°C, and then
the antibody-antigen complexes were precipitated with Pan-
sorbin (Calbiochem-Behring, La Jolla, Calif.) as described
previously (20).
Southern hybridizations. Southern transfer of DNA and
DNA-DNA hybridizations were performed as described by
Maniatis et al. (22). EcoRI-restricted DNA samples from
SLT-I phage 933J and from SLT-II phage 933W were nick
translated and used as probes to detect homologous phage
sequences in EcoRI-digested total cellular DNA prepara-
tions. Internal DNA probes from the SLT-I and SLT-II A
subunit genes were prepared by published procedures (9).
The SLT-I probe was a 250-bp HindIII to HpaI fragment
from pJN31, and the SLT-II probe was an 800-bp SmaI to
PstI fragment from pNN76.
Nucleotide sequence analysis. Subfragments of the recom-
binant plasmid pNAS4 were cloned into the M13 mpl8 and
mpl9 replicative-form vectors (36) to allow determination of
the nucleotide sequence of the Shiga toxin genes. Synthetic
oligonucleotides (model 380A DNA synthesizer; Applied
Biosystems, Inc., Foster City, Calif.) specific to the SLT-I
nucleotide sequence (18) were used as primers in the dide-
oxy chain-terminator method (2). The sequencing strategy is
depicted in Fig. 1. The amino acid sequences and biochem-
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ical properties of the Shiga toxin A and B subunits were
deduced with a DNA computer program (IBI/Pustell). A
computer search of GenBank (MicroGenie; Beckman Instru-
ments, Inc., Palo Alto, Calif.) revealed no significant homol-
ogies with bacterial or bacteriophage sequences.
RESULTS
Cloning of toxin genes. The genes for Shiga toxin were
cloned from total cellular DNA isolated from S. dysenteriae
type 1 3818T with the cosmid vector pHC79. Transductants
were initially screened for production of the B subunit with
a colony blot assay. Of 750 transductants screened, 3 carried
recombinant plasmids, designated pNAS1, pNAS2, and
pNAS3, which produced the B subunit. Transductants car-
rying pNAS2 or pNAS3 produced biologically active toxin,
as assayed in the HeLa cell cytotoxicity assay. The cytoto-
xin produced by these two transductants was neutralizable
with polyclonal antibodies against purified Shiga toxin and
MAbs against SLT-I. The toxin was not neutralizable with
polyclonal antibodies against crude SLT-II.
Digestion of plasmid DNAs from pNAS1, pNAS2, and
pNAS3 with HindIII, EcoRV, and EcoRI revealed common
restriction fragments. Digestion of pNAS2 and pNAS3 with
EcoRI showed a common fragment of approximately 5 kbp
that was absent in the nontoxigenic plasmid pNAS1. This
5-kbp EcoRI fragment was subcloned from pNAS2 into the
vector pACYC184 to produce the hybrid plasmid pNAS4
which carried the intact genes for Shiga toxin production. A
restriction map of the 5 kbp EcoRI fragment and the strategy
for subcloning and sequence analysis are shown in Fig. 1.
From the subcloning and sequence analyses, the A- and
B-subunit genes for Shiga toxin were located within a
3.2-kbp NcoI to EcoRI fragment, between the BglII and
HincIl restriction sites.
Minicell analysis. The polypeptides encoded by pNAS4
were analyzed in minicell experiments (Fig. 2A). The results
with minicells showed that pNAS4 encodes polypeptides
with the same apparent molecular weights as the SLT-I A
and B polypeptides encoded by pJN25, a recombinant
plasmid carrying the intact structural genes for SLT-I (26).
An A polypeptide with a molecular weight of approximately
32,500 and a B polypeptide with a molecular weight of
approximately 8,000 were identified from the minicells trans-
EcoRI
pNAS4 L
formed with pNAS4. Higher-molecular-weight forms (pre-
sumed to be unprocessed polypeptides with signal se-
quences) of the Shiga toxin and SLT-I A and B subunits
were also encoded by minicells (Fig. 2A). The processed and
unprocessed forms of the A and B polypeptides were absent
in the minicells carrying the vector plasmid pACYC184.
The radiolabeled toxins produced by minicells containing
pNAS4 or pJN25 were immunoprecipitated with either rab-
bit antiserum against purified Shiga toxin or MAbs against
SLT-I, and were analyzed by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis. Polypeptides corresponding
in molecular weights to the processed A subunit (Mr,
32,500), an A1 fragment (Mr, 27,500) which is the product of
proteolytic nicking (28), and the processed B subunit (Mr,
8,000) were immunoprecipitated by anti-Shiga or anti-Shiga-
like antibodies (Fig. 2B). No polypeptides were precipitated
by the control antibodies (normal rabbit serum and anti-
cholera toxin MAbs).
Sequence analysis of toxin genes. In Fig. 3 the nucleotide
and deduced amino acid sequences of stx A and stx B are
presented and compared with the slt-I A and slt-I B se-
quences as reported previously (18). The nucleotide and
amino acid sequences for stx A and slt-A differed by three
nucleotides, shown at positions 223, 359, and 850 in Fig. 3.
Only one of the three nucleotide differences between stx A
and slt-I A caused a change in the amino acid sequences. The
adenine to thymine transversion at nucleotide 359 resulted in
a substitution (albeit conservative) of a threonine in the
Shiga toxin sequence for a serine in the SLT-I sequence.
Nucleotide sequences (thus far determined) upstream and
downstream to the stx operon were identical to those re-
ported previously for the slt-I operon cloned from phage
933J (18). The Shiga toxin A and B subunits possessed signal
peptides of 22 and 20 amino acids, respectively (designated
by negative values in Fig. 3), which were identical to the
SLT-I A- and B-subunit signal peptides. Separation of the
signal peptides from the mature polypeptides at putative E.
coli signal peptidase I cleavage sites (33) resulted in a
processed Shiga toxin A subunit of 293 amino acids, with a
calculated molecular weight of 32,225, and a processed B
subunit of 69 amino acids, with a calculated molecular
weight of 7,691. The amino acid sequence of the Shiga toxin
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FIG. 1. Restriction map of Shiga toxin genes. Restriction sites are indicated within the 5-kbp EcoRI fragment isolated from the
recombinant plasmid pNAS4. Subclones carrying regions of the 5-kbp EcoRI fragment are shown, and their ability to produce biologically
active toxin and antigenically reactive B subunit is indicated on the right of the figure. The Shiga toxin structural genes, stx A and stx B, are
oriented above the restriction map. The strategy used to sequence the coding and noncoding strands of stx A and stx B is depicted by the
arrows below the map. Arrows preceded by a vertical line indicate subfragments sequenced by using the M13 universal primer. Arrows
preceded by a dot indicate where synthetic oligonucleotides specific to the SLT-I sequence were used as primers.
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FIG. 2. (A) Analysis of [35S]methionine-labeled proteins produced in minicells transformed with plasmids carrying the genes for SLT-1 or
Shiga toxin. Proteins were separated with a sodium dodecyl sulfate-15% polyacrylamide gel and visualized following autoradiography. Lane
A, Polypeptides encoded by pJN25, which carries the SLT-I genes; lane B, polypeptides encoded by pNAS4, which carries the Shiga toxin
genes; lane C, polypeptides encoded by the vector pACYC184 (control for pNAS4). Sizes and positions of molecular size standards (in
kilodaltons; low-molecular-weight standards; Bio-Rad Laboratories, Richmond, Calif.) are indicated on the right. The location of the
processed and unprocessed A (unprA) and B (unprB) subunits are indicated on the left. (B) Staphylococcus aureus protein A
immunoprecipitation of the [35S]methionine-labeled polypeptides produced by minicells carrying the SLT-I or Shiga toxin genes. Lanes A
through E, Polypeptides encoded by pJN25 that were specifically precipitated by rabbit anti-Shiga toxin (lane A), normal rabbit serum (lane
B), anti-SLT-1 MAb 16E6 (lane C), anti-SLT-1 MAb 13C4 (lane D), and anti-cholera toxin MAb 32D3 (lane E); lanes F through J, polypeptides
encoded by pNAS4 that were specifically precipitated by anti-Shiga toxin (lane F), normal rabbit serum (lane G), anti-SLT-1 MAb 16E6 (lane
H), anti-SLT-I MAb 13C4 (lane I), and anti-cholera toxin MAb 32D3 (lane J). The proteins were separated on a sodium dodecyl sulfate-15%
polyacrylamide gel and visualized following autoradiography. The positions of molecular size standards are indicated on the right; and the
positions of the A, Al, and B polypeptides are indicated on the left.
tical to that determined previously by using the purified
protein (38).
The structural genes of the Shiga toxin operon were
translated in frame and were organized tandemly with the
open reading frame of stx A 5' to the open reading frame of
stx B. An untranslated space of 12 nucleotides separated stx
A and stx B. A putative promoter sequence (35) was identi-
fied 5' to stx A (at nucleotides 19 and 42; underlined in Fig.
3). This promoter was the same promoter identified for the
slt-I operon (3, 7). It has been proposed that the sit-I operon
is repressed under iron replete conditions by the fur gene
product (4), and a putative binding site for the Fur protein
was identified in a region of dyad symmetry within the slt-I
promoter (4, 7). Because the promoter sequences of the stx
and sit-I operons were identical, it is likely that the negative
effect of iron on the expression of Shiga toxin is also
mediated by the fur gene product.
Two sequences homologous to the 3' end of E. coli 16S
rRNA (40) which could serve as ribosome-binding sites were
identified for both stx A and stx B (at nucleotides 145 and
1107, respectively; overlined in Fig. 3). Both the sequence
and position of the stx ribosome-binding sites were identical
to those reported previously for the sit-I operon (18). The
proposed mode of expression for the Shiga toxin operon was
identical to that proposed previously (18) for the sit-I op-
eron; i.e., the individual subunits are synthesized from a
polycistronic mRNA that is regulated by the promoter 5' to
stx A. Translation to give the individual A and B subunits
would be initiated from the independent ribosome-binding
sites. The existence of an additional ribosome-binding site
for stx B may function to give the holotoxin subunit ratio of
5B:1A (8). However, the effect of two different genetic
backgrounds, i.e., S. dysenteriae type 1 compared with E.
coii, on the expression of the Shiga toxin (sit-I) operon and
on the assembly of the holotoxin has yet to be determined.
Toxin production, phage induction, and Southern hybrid-
ization experiments. S. dysenteriae type 1 3818T and 60R, S.
flexneri M4243, S. boydii SF-bl, and S. sonnei SF-si were
studied for the production of cytotoxin that was antigenically
related to SLT-1 or SLT-II and for DNA sequences that were
related to the genes for SLT-1 or SLT-II. The results of these
experiments are summarized in Table 1. Various levels of
cytotoxin(s) were detected among all four species of Shi-
geila. However, high-level toxin production (>10' 50%
cytotoxic dose per ml of sonic lysate) was observed for S.
dysenteriae type 1 3818T and 60R only. The cytotoxic
activity detected for all strains of Shigeiia tested was neu-
tralizable with MAbs to SLT-I and not by polyclonal anti-
bodies to crude SLT-II. Southern hybridization experiments
performed under conditions that permitted no more than a
30% base-pair mismatch showed strong homology between
an internal probe for SLT-1 and single fragments of different
sizes from S. dysenteriae type 1 3818T and 60R (Fig. 4A).
With an extended time (11 days), additional bands of weak
homology were also detected among S. dysenteriae type 1
3818T and 60R and S. flexneri M4243 (Fig. 4B), but not
among S. sonnei or S. boydii. These fragments appeared to
be of the same or similar size in S. dysenteriae type 1 and S.
flexneri. Under the hybridization conditions described
above, no homology was detected between the internal
SLT-II probe and the cellular DNAs from the five strains of
Shigelia (data not shown).
The strains described above were also tested for UV- or








1120 STROCKBINE ET AL.
* . * 50 * *
TOACCAOATATOTTAAGGSOTBCTCTCSCTTAATATOATTAOTTTCATTACOSTATTTTACOTTTATCCGOTBC
a 100 ^ * a 150 a
OCCOTAAAACOCCOTCCTTCAGLBCBTOGAGOBATTCAAOAATATAOTTATCBTATSOTOCTCAZhYAT'SOTOTAAT
200 a a
ATO AAA ATA ATT ATT TTT AA OTO CTA ACT TTT TTC TTT OTT ATC mTI?CA OTT ALT GTO
Mot Lye II. Ile Ile Phe Arg Val Lou Thr Ph. Phe P?h Va1 Ile Phe 3er Va1 Lnn Val
-22
-10
B * 250 *
OTT OCO ABG BAA TTT ACC TTA OAC TTC TCO ACT OCA AAO ACO TAT OTL BAT TCO CTO AAT
Val Al. Lys Olu Ph. Thr Lou Asp Ph. Ser Thr li Lys Thr Tyr Va1 ALp Ser Lou ALn
+1 10
300 o
OTC ATT COC TCT OCA ATA GOT ACT CCL TTA CAB ACT LT TCA TCA GOA 0OT ACO TCT TTA
Vl IlIe Arg 8-r Al Ile Gly Thr Pro Lou Oln Thr IIl Sor Sor Oly Bly Thr Sor Lou
20 30
350 To . o 400
CTO ATa ATT OAT AOT OOC ACA BOB GAT ALT TTO TTT OCA OTT BAT GTC ABA BO ATA BAT
Lou Met Ile ALp Sor Gly Thr Gly Asp Len Lou Ph. li V1l Lop Va1 Arg Bly Ile Asp
40 Ser 50
* * . 0 450
CCL GAG BAA BOG COO TTT ALT AAT CTA COB CTT ATT OTT BAA COA ALT ALT TTA TAT OTO
Pro Olu Olu Oly Arg Ph. Aen Aon Lou Arg Lou Ile Va1 Olu Arg Len Aen Lou Tyr Vol
60 70
* * 0 500 0
ACA BOA TTT OTT AAC AGO ACA ALT ALT OTT TTT TAT COC TTT OCT OAT TTT TCA CAT OTT
Thr Oly Ph. Va1 ALn Arg Thr ALn ALn Val Phe Tyr Arg Pho Al ALp Ph. Sor His Val
s0 90
*0 550 0 *
ACC TTT CCA BOT ACA ACA GCO OTT ACA TTO TCT 00? OAC AOT AOC TAT ACC ACO TTA CAB
Thr Ph. Pro Bly Thr Thr Ala Val Thr Lou Sor Oly ALp Sor Ber Tyr Thr Thr Lou Oln
100 110
o 6000 0
COT OTT GCA BOG ATC AOT COT ACO BOO ATO CAG ATA ALT COC CAT TCO TTO ACT ACT TCT
Arg Va1 Al. Gly Ile Ser Arg Thr Oly Met Oln Ile Aen Arg His Sor Lou Thr Thr Sor
120 130
650 0 * * * 700
TAT CTG OAT TTA ATO TCO CAT AOT BOA ACC TCA CTO ACO CAB TCT OBO OCA AOL OCO ATO
Tyr Lou Asp Lou Met Sor His Sor Oly Thr Sor Lou Thr Oln Sr V1l Al Arg Al Mot
140 150
o . o 0 750
TTA COO TTT OTT ACT OTO ACA OCT BAA oC? TTA COT TTT CGO CAL ATA CAB AOB BOA TTT
Lou Arg Ph. Val Thr Val Thr Al Olu Al. Lou Arg Pho Arg Bin Ile Bin Arg Oly Phe
100 170
o * * 000 *
CBT ACA ACA CTO OAT BAT CTC AOT BOB COT TCT TAT OTA LbO AC? OC? BAA BAT OTT OAT
Arv Thr Thr Lou Lop Lop Lou Sor Gly Arg Ser Tyr V1l Mot Thr l Olu Lop Val Asp
1S0 190
o * C 0 0
CTT ACA TTO LAC TOO GOA LOB TTO AOT LOT OTC CTO CC? OAC TAT CAT BOA CAL OAC TCT
Lou Thr Lou ALn Trp Bly Arg Lou Ser Sor Val Lou Pro ALp Tyr Hio Bly Oln Asp Set
200 210
* 900 o 0g
OTT COT OTA BOA AOL ATT TCT TTT BOA AOC AT? A?T OC ATT CTO BOA ABC OTO BCA TTA
Val Arg Vol Oly Arg IIl Ser Ph. Gly Sor Ile Aen Ali Ile Lou Oly Sor Vol li Lou
220 230
950 0 0 ^ 1000
ATA CTO AAT TOT CAT CAT C?T OCA TCO COA OTT 0CC ABA ATO OCA TCT BAT OGO TT? CC?
Ile Lou ALn Cye His Hi His Al S*rt rg Val li Arg Met Al Sor Asp Olu Phe Pro
240 250
o * e o 1050
TC? ATO TOT CCO OCA BAT BOA AGO OTC COT BO AT? ACO CAC ALT ALL ATA TTO TOO OAT
Sor Mot Cys Pro Ala Asp Oly Arg Val Arg Oly 1. Thr His Aen Lys II. Lou Trp Asp
200 270
o * 0 1100
TCA TCC ACT CTO GOO OCA AT? CTO ATO COC ABA ACT ATT AOC LOT TA gin 0o0 AL
S*r Ser Thr Lou Oly Al Ile Lou Mot Arg Arg Thr Io Sor S*r ---
280 290
o ^ ^ 1150 o
ATO ALL ALA ACA ITL TTA ATA BCT OCA TCO CTT TCA TTT STT ;CA OCA AOT OCO CTO OCO
Met Lys Lye Thr Lou Lou Ile li Al. Ser Lou Sor Ph. Phb 3er Al Sor Ali Lou Al
-20
-10
o o 1200 o o
ACO CCT OAT TO?OTA ACT BO ALA OTO GAB TAT ACA ALA TAT AL? BAT OAC GAT ACC TTT
Thr Pro Aep Cye Vol Thr Oly Lys Va1 Olu Tyr Thr Lys Tyr Len Asp Asp Aep Thr Phe
o1 10 20
o 1250 * ^ 0
ACA OTB ALL OTB OT OAT ALL BAA TTA TTT ACC AAC AOL TOO A?T CTT CAB TCT CTT CT?
Thr Val Lys Val Oly Asp Lys Olu Lou Ph. Thr ALn Arg Trp Len Lou Bln Sor Lou Lou
30 40
1300 o 0 o o 1350
CTC LOT OCO CAL ATT ACO BOB ATO ACT OTA ACC ATT ALL ACT A?T OCC TOT CAT ALT BOA




BOB BOA TTC AOC BAA OTT ATT TTT COT TOA CTCAGALTAOCBTCAOTBAAATAOCABOCOOGAATTCAT
Oly Oly Ph. S*r Olu Vol Ile Ph. Arg
0
" 1450 0 e * I100
LAAA?TTAAATACLTCTCAATTCAoTCAoTTOTTBCCoOTTCTOATAATAoATBTOTToALAATTTCTBCLATO
FIG. 3. Nucleotide sequence of the stx A and stx B structural
genes. The nucleotides are numbered above the sequence. Transla-
tion of the sequence gave an open reading frame for the A-subunit
gene between nucleotides 161 and 1106 and an open reading frame
for the B-subunit gene between nucleotides 1118 and 1385. The
amino acids are numbered below the sequence. The amino-terminal
residues of the processed A and B subunits are depicted as +1.
Three nucleotide differences between stx A and slt-I A are shown
above the Shiga toxin sequence, at positions 223, 359, and 850. The
A.










FIG. 4. Southern blot analysis of EcoRI-restricted total cellular
DNA from S. dysenteriae type 1 60R (lanes A), S. dysenteriae type
1 3818T (lanes B), S. flexneri type 2a M4243 (lanes C), S. boydii
SF-bl (lanes D), and S. sonnei SF-si (lanes E) probed with the
32P-labeled, 250-bp HindIII-HpaI fragment internal to slt-I A. (A)
Exposure for 2.8 days. (B) Exposure for 11 days, demonstrating
homology between the SLT-I probe and total cellular DNA from S.
flexneri (lane C). The positions of lambda-HindIII fragments (size
markers) are indicated on the left of the figure.
sequences related to the SLT-I- or SLT-II-converting phages
from E. coli 933. No phages were detected by using E. coli
K-12 C600 and HB101 as the host bacteria for the plaquing
experiments (Table 1). Total cellular DNA from the five
strains of Shigella was probed under hybridization condi-
tions that permitted up to 30%o base-pair mismatch with
genomic DNA from SLT-I-converting phage 933J or SLT-
II-converting phage 933W. Sequences related to phage 933J
were detected in S. dysenteriae type 1 3818T and 60R and S.
flexneri M4243, but not in S. sonnei SF-sl or S. boydii
SF-bl. No sequences related to phage 933W were detected
in any of the strains tested (data not shown).
DISCUSSION
In the studies reported here, the structural genes for Shiga
toxin from S. dysenteriae type 1 3818T were cloned and the
single amino acid difference between Shiga toxin and SLT-I is
shown below the sequence, at residue 45. A putative promoter
sequence (35) is underlined at nucleotides 19 to 24 (-35) and 42 to 47
(-10). Two potential ribosome-binding sites (40) are overlined
beginning at nucleotides 145 (5' to stx A) and 1107 (5' to stx B). The
nucleotide sequence of SLT-I reported previously (18) was cor-
rected here. This sequence contained three fewer T residues in the
first 150 bp.
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TABLE 1. Toxin production and phage induction in Shigella spp.
Toxin production Neutralization by: Phage induction by:(CD5sWmI) of~:
Strain Rabbit MAb Rabbit
Lysate Supernatant anti- anti- anti- UV light Mitomycin C
Shiga SLT-I SLT-II
S. dysenteriae type 1
3818T 106_107 106 + + - - -
60R 106_107 106 + + - - -
S. flexneri type 2a M4243 320 NKb + + - - -
S. boydii SF-bl 80 NK + + - - -
S. sonnei SF-si 80 NK + + - - -
a CD50, Cytotoxic dose of 50%o.
b NK, No kill in the HeLa cell cytotoxicity assay.
nucleotide sequences were determined. The nucleotide se-
quences of three members of the Shiga toxin gene family,
SLT-I (18), SLT-II (17), and Shiga toxin, have now been
determined. These sequence analyses define a relationship
among the Shiga toxin and SLT genes and suggest models of
evolution. We have shown previously (17) that SLT-I and
SLT-II share limited regions of high nucleotide sequence
homology (greater than 70%) but are only 55% homologous
overall. This indicates that the SLT-I and SLT-II genes
diverged from each other in the distant past, prior to the
evolution of S. dysenteriae type 1 and E. coli as separate
genera. In contrast, the Shiga toxin and SLT-I nucleotide
sequences were greater than 99% homologous, and transla-
tion of the nucleotide sequences revealed that Shiga toxin
and SLT-I were essentially identical toxins. This high degree
ofgenetic relatedness would be expected to exist between an
individual gene isolated from two separate bacterial strains
of the same species.
At this time it is not possible to ascertain the origin of the
Shiga toxin or SLT-I genes. Since SLT-I is encoded by a
temperate coliphage, transduction could serve to dissemi-
nate the toxin structural genes among related bacteria.
Although attempts to induce phage from several strains of
Shigella were unsuccessful (Table 1), DNA sequences ho-
mologous to the SLT-I-converting phage 933J were detected
within S. dysenteriae type 1 and S. flexneri type 2A (data not
shown). These sequences may represent (i) a defective or
incomplete phage in Shigella species which is no longer
inducible or (ii) a related phage that is not inducible with
either UV light or mitomycin C or does not form plaques on
E. coli K-12 HB101 or C600.
The results of this study support the nomenclature estab-
lished previously (30) for the Shiga-related toxins because
they reveal the near identity between the sequences of SLT-I
and Shiga toxin. Shigella toxin was described in 1903, prior
to the discovery of any related cytotoxins in E. coli or
related genera. To avoid confusion, the designation SLT
should be used for toxin variants isolated from bacteria other
than S. dysenteriae type 1 which share antigenic or biologic
properties with Shiga toxin. The designations SLT-I, SLT-
II, etc., should be assigned on the basis of the sequence
relatedness of a new antigenic variant to the prototypic
cytotoxin genes described previously.
A definitive role for Shiga toxin in diarrheal disease has
not yet been demonstrated. Studies with nonisogenic strains
of Shigella differing in toxin production or invasiveness (an
essential virulence trait) have produced inconclusive results
about the role of toxin in the pathogenesis of shigellosis (13).
The data reported here should facilitate the construction of
isogenic strains of Shigella that differ only in the ability to
produce toxin. These strains could be used in animal studies
to clarify the role of Shiga toxin in the pathogenesis of
shigellosis and hemolytic uremic syndrome.
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